Koers Sigilon Therapeutics, Inc.
Aandelen
SGTX
US82657L2060
Biotechnologie & Medisch Onderzoek
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 60 | 14-08-18 | |
Director of Finance/CFO | 58 | 01-11-19 | |
Philip Johnson
PSD | President | 59 | 11-08-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 60 | 14-08-18 | |
Philip Johnson
PSD | President | 59 | 11-08-23 |
Gordon Brooks
BRD | Director/Board Member | - | 11-08-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,78% | 45,97 mld. | |
+53,07% | 43,93 mld. | |
+10,04% | 42,34 mld. | |
-8,59% | 28,27 mld. | |
+17,43% | 27,18 mld. | |
-20,33% | 19,44 mld. | |
+13,84% | 13,83 mld. | |
+31,33% | 12,4 mld. | |
+8,79% | 11,45 mld. |